HYUNDAI BIOLAND Co.Ltd (052260)
KOSDAQ · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 4,325.00 |
|---|---|
| 52-week range | 3,125.00 – 6,240.00 |
| Return, 1 month / 3 months | +8.5% / +28.9% |
| Return, 1 year / 3 years | −3.1% / −3.0% |
| Trend | Uptrend |
| RSI (14) | 46 |
| Volatility (1 year) | 41.4% |
| Worst drawdown (1 year) | -31.8% |
| Average daily value traded | 3,888.47M KRW |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hyundai Bioland is a South Korean cosmetics company that develops, manufactures and markets skincare and makeup products. It sells its own brands to consumers in Korea and overseas, and it also runs an original development manufacturing business that produces cosmetics for other companies. Its product range covers everyday skin care items such as creams, masks and cleansers along with colour cosmetics. The company is based in South Korea and serves both domestic and international beauty markets.
On this site HYUNDAI BIOLAND Co.Ltd appears as a stock on the KOSDAQ (Korea), code 052260, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HYUNDAI BIOLAND Co.Ltd (052260) trades on the KOSDAQ in Korea. It last closed at KRW 4,325.00 on 23 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 26 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.1% and over the last three months it rose 28.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.0% | ||
| From 52-week high | -23.7% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.9% | ||
| 6-month return | 1.1% | ||
| 12-month return, skipping the last month | -10.7% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.8% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 3,888.47M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | +8.5% |
| 3 months | +28.9% |
| 6 months | +1.1% |
| 1 year | −3.1% |
| 3 years | −3.0% |
| 5 years | −52.6% |
Signals
| 50-day / 200-day average | 4,253.10 / 4,041.27 |
|---|---|
| Golden / death cross (60 days) | Golden, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 246.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | KRW 70.0000 |
| 27 Dec 2024 | KRW 70.0000 |
| 27 Dec 2023 | KRW 70.0000 |
| 28 Dec 2022 | KRW 70.0000 |
| 29 Dec 2021 | KRW 70.0000 |
| 29 Dec 2020 | KRW 100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.